T2 Biosystems, Inc. (TTOO): Price and Financial Metrics

T2 Biosystems, Inc. (TTOO): $3.93

0.25 (-5.98%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

D

TTOO Price/Volume Stats

Current price $3.93 52-week high $70.00
Prev. close $4.18 52-week low $3.36
Day low $3.60 Volume 232,700
Day high $4.33 Avg. volume 264,164
50-day MA $4.87 Dividend yield N/A
200-day MA $12.74 Market Cap 15.92M

TTOO Stock Price Chart Interactive Chart >

TTOO POWR Grades

  • Growth is the dimension where TTOO ranks best; there it ranks ahead of 87.33% of US stocks.
  • The strongest trend for TTOO is in Growth, which has been heading up over the past 140 days.
  • TTOO's current lowest rank is in the Stability metric (where it is better than 0.85% of US stocks).

TTOO Stock Summary

  • Revenue growth over the past 12 months for T2 BIOSYSTEMS INC comes in at -53.8%, a number that bests merely 4.29% of the US stocks we're tracking.
  • In terms of volatility of its share price, TTOO is more volatile than 99.83% of stocks we're observing.
  • T2 BIOSYSTEMS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -213.28%, greater than the shareholder yield of just 2.09% of stocks in our set.
  • Stocks that are quantitatively similar to TTOO, based on their financial statements, market capitalization, and price volatility, are CHRS, RFL, AXTI, INTZ, and LAW.
  • TTOO's SEC filings can be seen here. And to visit T2 BIOSYSTEMS INC's official web site, go to www.t2biosystems.com.

TTOO Valuation Summary

  • In comparison to the median Healthcare stock, TTOO's price/sales ratio is 45.24% lower, now standing at 2.3.
  • TTOO's price/sales ratio has moved down 1764.8 over the prior 114 months.

Below are key valuation metrics over time for TTOO.

Stock Date P/S P/B P/E EV/EBIT
TTOO 2023-12-29 2.3 -1.3 -0.5 -1.1
TTOO 2023-12-28 2.7 -1.6 -0.6 -1.2
TTOO 2023-12-27 1.9 -1.1 -0.4 -1.0
TTOO 2023-12-26 1.8 -1.0 -0.4 -1.0
TTOO 2023-12-22 1.9 -1.1 -0.4 -1.0
TTOO 2023-12-21 1.8 -1.0 -0.4 -1.0

TTOO Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at -8.1%.
  • Its 5 year price growth rate is now at -85.29%.
  • The 4 year net income to common stockholders growth rate now stands at -4.86%.
Over the past 33 months, TTOO's revenue has gone up $15,467,000.

The table below shows TTOO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 23.802 -50.142 -64.378
2022-06-30 27.553 -43.966 -60.635
2022-03-31 28.336 -44.607 -55.076
2021-12-31 28.058 -38.874 -49.241
2021-09-30 28.866 -37.782 -47.006
2021-06-30 26.683 -34.289 -44.299

TTOO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TTOO has a Quality Grade of D, ranking ahead of 16.98% of graded US stocks.
  • TTOO's asset turnover comes in at 0.387 -- ranking 118th of 186 Medical Equipment stocks.
  • ICAD, STRR, and DRIO are the stocks whose asset turnover ratios are most correlated with TTOO.

The table below shows TTOO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.387 0.210 -0.411
2021-06-30 0.349 0.066 -0.396
2021-03-31 0.321 0.006 -0.405
2020-12-31 0.277 -0.174 -0.620
2020-09-30 0.254 -0.298 -1.132
2020-06-30 0.235 -0.476 -2.605

TTOO Price Target

For more insight on analysts targets of TTOO, see our TTOO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.20 Average Broker Recommendation 1.3 (Strong Buy)

T2 Biosystems, Inc. (TTOO) Company Bio


T2 Biosystems develops diagnostic products and product candidates for the detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company was founded in 2006 and is based in Lexington, Massachusetts.


TTOO Latest News Stream


Event/Time News Detail
Loading, please wait...

TTOO Latest Social Stream


Loading social stream, please wait...

View Full TTOO Social Stream

Latest TTOO News From Around the Web

Below are the latest news stories about T2 BIOSYSTEMS INC that investors may wish to consider to help them evaluate TTOO as an investment opportunity.

Get Out Now! 7 Stocks That Are Destined to Die

Looking to optimize your portfolio?

Muslim Farooque on InvestorPlace | November 11, 2023

T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

LEXINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NY. Management is scheduled to present on Thursday, November 16, 2023, at 8:00am ET. Interested parties may access a live and recorded webcast of the presentation

Yahoo | November 3, 2023

TTOO Stock Alert: T2 Biosystems Regains Nasdaq Compliance

TTOO stock is back above $1 and is now officially in compliance with Nasdaq's minimum bid price requirement of $1.

Eddie Pan on InvestorPlace | November 1, 2023

T2 Biosystems Regains Compliance with Nasdaq Listing Requirements

LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on October 31, 2023 it received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Lis

Yahoo | November 1, 2023

T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference

Data demonstrates speed, accuracy, and clinical benefits of the T2Dx Instrument and T2 Biosystems’ sepsis panels, including encouraging early detection data for T2Resistance PanelLEXINGTON, Mass., Oct. 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted four new studies supporting the T2Bacteria® Panel, the T2Candida® Panel and the T2Resistance® Panel that were recently pres

Yahoo | October 24, 2023

Read More 'TTOO' Stories Here

TTOO Price Returns

1-mo -27.89%
3-mo -25.85%
6-mo -86.44%
1-year -91.90%
3-year -99.96%
5-year -99.97%
YTD -37.37%
2023 -95.58%
2022 -94.50%
2021 -58.37%
2020 5.98%
2019 -61.13%

Continue Researching TTOO

Want to see what other sources are saying about T2 Biosystems Inc's financials and stock price? Try the links below:

T2 Biosystems Inc (TTOO) Stock Price | Nasdaq
T2 Biosystems Inc (TTOO) Stock Quote, History and News - Yahoo Finance
T2 Biosystems Inc (TTOO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!